Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Specific Population

Filter by Topic

Filter by Infection

Hepatitis C (remove)
HIV (3)

Filter by Resource Category

Search results

Current filters: Hepatitis C drugs, Hepatitis C

55 search results

1
2
3
4
5

FDA—Rare cases of liver injury with some hepatitis C treatments: 2019, CATIE
Research summary - Webpage
Maviret for hepatitis C treatment enters the Ontario drug formulary: 2019, CATIE
Research summary - Webpage
About HCV drugs in Canada: From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage
Maviret for people with HCV and chronic kidney disease: From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage
Experience with Maviret in northern Italy: From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage
Germany—experience with Maviret after licensure: From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage
HCV cure and the long road to recovery: From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage
HCV treatment in advanced liver disease: From TreatmentUpdate 227
2018, CATIE
Research summary - Webpage
Hepatitis C treatment in the new DAA era: frontline implications: 2020, CATIE
Webinar - Video
Vosevi (sofosbuvir + velpatasvir + voxilaprevir): 2019, CATIE
Fact sheet - Webpage

1
2
3
4
5

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.